JAN CEYSSENS: Open Payments
NPI 1831608512 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 22 payments from 9 companies in 2025. Trend: 2023 $35 · 2024 $298 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $109 |
| Novo Nordisk Inc | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| PFIZER INC. | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: Wegovy, CAMZYOS, MYCARELINK, REPATHA, LifeVest, LINQ II, ELIQUIS, AURORA EV-ICD MRI SURESCAN.
Industry payments across GA — which companies pay providers there.
